Skip to main content
. 2024 Mar 4;14:1323192. doi: 10.3389/fonc.2024.1323192

Table 5.

Association between serum albumin levels and cancer mortality in different subgroups.

Groups Cancer mortality (Per 1g/dL albumin decrease)
Crude
HR (95% CI)
P
for trend
Adjusted
HR (95% CI)
P
for trend
Male 3.34 (2.76, 4.06) < 0.01 2.17 (1.75, 2.68) < 0.01
Female 2.38 (1.88, 2.89) < 0.01 1.81 (1.43, 2.27) < 0.01
Age ≤ 69 2.47 (1.87, 3.25) < 0.01 2.39 (1.76, 3.24) < 0.01
Age>69 2.23 (1.87, 2.65) < 0.01 1.85 (1.56, 2.23) < 0.01
BMI ≤ 27.8 2.86 (2.37, 3.36) < 0.01 1.77 (1.45, 2.16) < 0.01
BMI>27.8 2.22 (1.76, 2.79) < 0.01 2.53 (1.94, 3.29) < 0.01
Hypertension 2.25 (1.88, 2.69) < 0.01 1.65 (1.25, 2.18) < 0.01
Non-hypertension 2.34 (1.83, 2.98) < 0.01 2.24 (1.85, 2.71) < 0.01
Diabetes mellitus 2.41 (1.83, 3.17) < 0.01 2.42 (1.80, 3.25) < 0.01
Non-Diabetes mellitus 2.23 (1.89, 2.64) < 0.01 1.90 (1.58, 2.28) < 0.01
CVD 1.96 (1.53, 2.49) < 0.01 1.94 (1.49, 2.54) < 0.01
Non-CVD 2.28 (1.91, 2.72) < 0.01 2.06 (1.70, 2.50) < 0.01

Age and BMI were grouped according to their median. Crude model: adjusted for none. Adjusted model: adjusted for age, sex, ethnicity, BMI, smoking, drinking, hypertension, diabetes mellitus, anemia, CVD. HR, Hazard ratio and CI, confidence interval.